Related Experiment Video
Updated: Sep 10, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Case report: Bladder carcinoma with shadow cell differentiation: a case report with immunohistochemical analyses
Raja Jouini1, Imen Guesmi1, Imen Helal1
1Tunis El Manar University, Faculty of Medicine of Tunis, 1007 Tunis, Tunisia; Habib Thameur Hospital, Department of Pathology, Tunis, Tunisia.
This study reports a rare case of bladder carcinoma featuring shadow cell differentiation (SCD), a unique keratinization pattern. Recognizing this variant is crucial for accurate diagnosis and management of urothelial neoplasms.
Area of Science:
- Oncology
- Pathology
- Urology
Background:
- Bladder carcinoma presents diverse histological subtypes.
- Shadow cell differentiation (SCD) is an exceptionally rare feature in bladder cancer, mimicking cutaneous pilomatricoma.
- Understanding rare histological variants is vital for accurate cancer diagnosis.
Observation:
- A 67-year-old male smoker presented with lumbar pain, hematuria, and dysuria.
- Imaging revealed a 3 cm bladder tumor with suspicious lung and mediastinal masses.
- Transurethral resection showed high-grade urothelial carcinoma with squamous differentiation and SCD.
Findings:
- The bladder tumor exhibited high-grade urothelial carcinoma with partial squamous differentiation and shadow cell differentiation (SCD).
- Immunohistochemistry confirmed positive β-catenin in the peripheral squamous component.
- SCD, typically seen in hair matrix, was observed as a keratinization variant in this bladder carcinoma.
Implications:
- This case highlights the occurrence of SCD in bladder carcinoma, a rare phenomenon.
- Recognizing SCD in urothelial neoplasms is important for precise histopathological diagnosis.
- Further research into SCD in carcinomas may elucidate novel keratinization pathways and therapeutic targets.
More Related Videos
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015